期刊文献+

肌萎缩侧索硬化患者血清肌酐水平的研究 被引量:7

Evaluation of serum creatinine level in amyotrophic lateral sclerosis patients
原文传递
导出
摘要 目的 探讨散发性肌萎缩侧索硬化(sALS)患者血清肌酐(SCr)水平及其与临床指标的关系.方法 测定sALS、多系统萎缩(MSA)和紧张型头痛(TTH)各80例患者的SCr水平,分析sALS患者SCr水平与肌萎缩侧索硬化功能评分(ALSFRS-R)、用力肺活量(FVC)占预计值百分比、起病部位、病程和疾病进展速率之间的关系.结果 sALS组SCr水平低于MSA组和TTH组,差异有统计学意义[(60.86±16.80)μmol/L比(70.05±12.79) μmol/L和(66.97±14.14)μmol/L,P<0.01];MSA组与TTH组SCr水平的差异无统计学意义(P =0.141).sALS患者SCr水平与ALSFRS-R呈正相关(r =0.315,P=0.005),而与FVC占预计值百分比、起病部位、病程和疾病进展速率无明显相关性(P值均>0.05).结论 SCr水平是sALS的一项重要生化指标,对监测疾病进展可能具有重要的作用. Objective To investigate the serum creatinine (SCr) level in patients with sporadic amyotrophic lateral sclerosis (sALS) and to explore the relationship between the SCr level and the clinical characteristics.Methods A total of 80 patients with sALS,80 patients with multiple system atrophy (MSA) and 80 patients with tension-type headache (TTH) were enrolled in the study.The SCr levels were compared among the three groups.The association between the SCr level and the revised Amyotrophic Lateral Sclerosis Functional Rating Scale (ALSFRS-R),the forced vital capacity (FVC) percentage of predicted (FVC% pred),the site of symptom onset,the duration of disease and the rate of disease progression was evaluated in the sALS group.Results The SCr level was significantly decreased in the sALS group than the other two groups [(60.86 ± 16.80) μmol/L vs (70.05 ± 12.79) μmol/L and (66.97-± 14.14) μmol/L,P 〈 0.01].In the sALS group,the SCr level was positively correlated with the ALSFRS-R (r =0.315,P =0.005),while no correlation was found between the SCr level and the FVC% pred,the site of symptom onset,the duration of disease and the rate of disease progression (all P 〉 0.05).Conclusion The SCr level is an important biochemical index in the patients with sALS and might play an important role in monitoring the disease progression.
出处 《中华内科杂志》 CAS CSCD 北大核心 2014年第4期283-285,共3页 Chinese Journal of Internal Medicine
关键词 肌萎缩侧索硬化 肌酸酐 Amyotrophic lateral sclerosis Creatinine
  • 相关文献

参考文献6

  • 1鲁明,康德瑄,樊东升,王新慧,赵华,陈清棠.肌萎缩侧索硬化患者脑脊液中谷氨酸水平增高[J].中华内科杂志,2003,42(3):152-152. 被引量:5
  • 2Liu GT, Hwang CS, Hsieh CH, et al. Eosinophil-defived neurotoxin is elevated in patients with amyotrophic lateral sclerosis [J]. Mediators Inflamm ,2013,2013 : 421389.
  • 3Brooks BR, Miller RG, Swash M, et al. E1 Eseorial revisited: revised criteria for the diagnosis of amyotrophie lateral sclerosis [ J ]. Amyotroph Lateral Scler Other Motor Neuron Disord,2000, 1 : 293-299.
  • 4Ikeda K, Hirayama T, Takazawa T, et al. Relationships between disease progression and serum levels of lipid, urate, creatinine and ferritin in Japanese patients with amyotrophic lateral sclerosis: a cross-sectional study[J]. Intern Med,2012,51 : 1501-1508.
  • 5Tetsuka S, Morita M, Ikeguehi K, et al. Utility of cystatin C for renal function in amyotrophic lateral sclerosis [ J ]. Acta Neurol Scand ,2013,128:386-390.
  • 6Franchignoni F, Mora G, Giordano A, et al. Evidence of multidimensionality in the ALSFRS-R Scale: a critical appraisal on its measurement properties using Raseh analysis [ J ]. J Neurol Neurosurg Psychiatry ,2013,84 : 1340-1345.

共引文献4

同被引文献36

  • 1师萍,罗殿熙,陈天洋.各时段尿肌酐排出量与24小时排出量的关系探讨[J].贵州医药,2005,29(12):1099-1100. 被引量:1
  • 2Sher RB, Heiman-Patterson TD, Blankenhom EA, et al. A major QTL on mouse chromosome 17 resulting in lifespan variability in SOD1-G93A transgenic mouse models of amyotrophic lateral sclerosis [J]. Amyotroph Lateral Scler Frontotemporal Degener, 2014, 15(7-8): 588-600.
  • 3D Amico E, Factor-Litvak P, Santella RM, et al. Clinical perspective on oxidative stress in sporadic amyotrophic lateral sclerosis[J]. Free Radic Biol Med, 2013, 65(12): 509-527.
  • 4Wang F, Lu Y, Qi F, et al. Effect of the human SOD1-G93A gene on the Nrf2/ARE signaling pathway in NSC-34 cells[J]. Mol Med Rep, 2014, 9(6): 2453-2458.
  • 5Hadzhieva M, Kirches E, Wilisch-Neumann A, et al. Dysregulation of iron protein expression in the G93A model of amyotrophic lateral sclerosis[J]. Neuroscience, 2013, 29(1): 94-101.
  • 6Yu J, Qi F, Wang N, et al. Increased iron level in motor cortex of amyotrophic lateral sclerosis patients: An in vivo MR study [J]. Amyotroph Lateral Scler Frontotemporal Degener, 2014, 15(5-6): 357-361.
  • 7Yu J, Guo Y, Sun M, et al. Iron is a potential key mediator of glutamate excitotoxicity in spinal cord motor neurons [J]. Brain Res, 2009,1257(2): 102-107.
  • 8Jomova K, Vondrakova D, Lawson M, et al. Metals, oxidative stless and neurodegenerative disorders[J]. Mol Cell Biochem, 2010, 345 (l-2): 91-104.
  • 9Wang Q, Zhang X, Chen S, et al. Prevention of motor neuron degeneration by novel iron chelators in SOD1G93A transgenic mice of amyotrophic lateral sclerosis[J]. Neurodegener Dis, 2011, 8 (5): 310-321.
  • 10Garrido-Gil P, Rodriguez-PaIlares J, Dominguez-Meijide A, et al. Brain angiotensin regulates iron homeostasis in doparninergic neurons and microglial cells [J]. Exp Neurol, 2013, 250 (12): 384-396.

引证文献7

二级引证文献28

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部